Gut Microbiota biomarkers associated with improved drug response, as well as genomic biomarkers for early detection of patients at risk were identified using Ariana’s KEM® Explainable AI (XAI) in 3 separate oral presentations. […]
Initial results of Onco KEM and the WINTHER trial were presented at TAT 2017: 15th International Congress on Targeted Anticancer Therapies, 6-8 Mar 2017, Paris, France. […]
Dr Afshar will participate in DITEP 2016 - Gustave Roussy's day on innovations and challenges of early drug development in oncology on 9 Dec 2016 in Paris.
CEO Mohammad Afshar presents very practical uses of Artificial Intelligence for healthcare at Club Digital Santé in Paris on December 8th.
Dr Parmentier will present a poster “Combination Therapy in Melanoma: finding biomarkers of synergistic associations using Large Scale Drug Combination Screening and integrated Omics Data Analysis” at the Institut Pasteur International Network Scientific Symposium in Paris on November 30th. […]
Dr Afshar will deliver his address on "Impact, Process and Cost of Including Data mining in Early Drug Development" to the Early Drug Development Association in Paris on 24 Nov.
Dr David Morley, VP Computational Technology, will be co-presenting a poster at the 65th Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH 2016) in Atlanta, USA. […]
Dr Afshar will moderate a panel on End-to-End Companion Diagnostics Development at 2nd Annual Personalised Medicines and Cancer Biomarkers 2016 in London on 12-13 October 2016.
Dr Kuras (CTO) shares her expertise at this leading Biomarkers International Conference and will deliver a presentation on "Transforming Big Data towards Therapeutic Decision Systems"
The WIN 2016 Symposium is the place to be to learn about the latest in cancer research by world class presenters. Come and meet the Ariana team of Dr Mohammad Afshar, Dr Guergova-Kuras, Dr Morley and Dr Vaucouleur.